跳至主要内容
临床试验/NCT04646876
NCT04646876已完成3 期

Assessment Role of Mgso4 as Neuroprotective in Post Traumatic Brain Injury

Osama Mohamed Abdelwahab1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年5月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Glasgow outcome scale after 2 months

研究概览

简要总结

The aim of this study is to assess the potential role of magnesium sulphate (MgSo4) as a neuroprotective agent using the Glasgow outcome scale following moderate and severe traumatic brain injury.

详细描述

The study is Prospective , Comparative , double-blind , placebo-controlled study with randomization

Patients with post traumatic brain injury either moderate (glasgow coma scale GCS = 9-12) or severe (GCS = 3-8) admitted in one of the neurosurgical ICU of the following centers; kasr El Aini Hospitals, Beni- Suef University Hospital or Beni- Suef General Hospital.

Study design and statistical inferences Patients with traumatic brain injury included in the study will be randomly allocated into one of two equal groups (30 patients each): -

Group (A): will receive MgSo4. Group (B): will receive normal saline as a placebo.

Each patient will receive all other standard management as indicated on individual basis (e.g. Antiepileptics, brain dehydrating measures, antibiotics, ventilatory support, or surgical intervention when deemed necessary).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

The researcher did not know the type of medication given to the patients, placebo or treatment actually Only investigator knew the key

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with moderate (GCS = 9-12), or severe (GCS = 3-8) traumatic brain injury.
  • Age above 12 years.
  • Consenting for treatment within 24 hours of trauma.

排除标准

  • Non consenting patients.
  • Persistent hypotension (BP below 90 / 60) in 1st 24 hours despite measures of resuscitation.
  • Significant multisystem association (e.g. cord injury with spinal shock).
  • Known case of renal failure

研究组 & 干预措施

intervention arm ( Group A )

Active Comparator

including 30 patients Group A was given magnesium Sulphate

Administration regimen of Mgso4 was as following:

Initial dose: within 24 hrs of trauma 50 mg / kg / IV infusion over 1 hour. Maintenance dose: (25 mg / kg) per dose twice daily for 48 hrs.

干预措施: Magnesium Sulfate (Drug)

Placebo arm (Group B )

Placebo Comparator

including 30 patients Placebo control study Group B was given saline as a placebo. with the same regimen and route of administration of magnesium sulphate

干预措施: Placebo (Drug)

结局指标

主要结局

Glasgow outcome scale after 2 months

时间窗: 60 days from drug administration

assessment of conscious level of the patients after 60 days of drug administration The Glasgow outcome scale (GOS) has been used to categorize the outcome after 2 months as follows: 1. Death. 2. Persistent vegetative state: Minimal responsiveness. 3. Severe disability: Conscious but disabled; dependent on others for daily support. 4. Moderate disability: Disabled but independent; can work in sheltered setting. 5. Good recovery: Resumption of normal life despite minor deficits. Better score means that the patient conscious level is improved

次要结局

未报告次要终点

研究者

发起方
Osama Mohamed Abdelwahab
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Osama Mohamed Abdelwahab

Professor Osama Mohamed Abdelwahab

Cairo University

研究点 (1)

Loading locations...

相似试验